Ovid Therapeutics Inc (OVID)

May 13, 2025

Ovid Therapeutics Reports Business Updates and First Quarter 2025 Financial Results - GlobeNewswire

May 13, 2025

May 13, 2025

Ovid Therapeutics (OVID) Exceeds Q1 Revenue Expectations and Adv - GuruFocus

May 13, 2025

May 13, 2025

Ovid Therapeutics (OVID) Reports $43 Million in Cash Reserves | - GuruFocus

May 13, 2025

May 13, 2025

Ovid Therapeutics Reports Business Updates and First Quarter 202 - GuruFocus

May 13, 2025

May 13, 2025

Ovid Therapeutics (OVID) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 13, 2025

May 13, 2025

Ovid Therapeutics Inc Reports Q1 2025 EPS of -$0.14, Meeting Est - GuruFocus

May 13, 2025

May 13, 2025

Ovid Therapeutics Inc. SEC 10-Q Report - TradingView

May 13, 2025

May 13, 2025

Ovid Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 13, 2025

May 11, 2025

Ovid Therapeutics (OVID) Projected to Post Quarterly Earnings on Tuesday - Defense World

May 11, 2025

May 08, 2025

Ovid Therapeutics Inc. (NASDAQ:OVID) Shares Purchased by Renaissance Technologies LLC - Defense World

May 08, 2025

May 06, 2025

Ovid Therapeutics (OVID) May Report Negative Earnings: Know the Trend Ahead of Q1 Release - Yahoo Finance

May 06, 2025

May 05, 2025

Ovid Therapeutics Reports Business Updates and Third Quarter 2024 Financial Results - ADVFN

May 05, 2025

May 05, 2025

Dup15q syndrome Market: Epidemiology, Therapies, Companies, - openPR.com

May 05, 2025

Apr 27, 2025

JPMorgan Chase & Co. Decreases Stock Holdings in Ovid Therapeutics Inc. (NASDAQ:OVID) - Defense World

Apr 27, 2025

Apr 27, 2025

Ovid Therapeutics (NASDAQ:OVID) Upgraded at William Blair - Defense World

Apr 27, 2025

Apr 25, 2025

Analysts Set Ovid Therapeutics Inc. (NASDAQ:OVID) Target Price at $3.03 - Defense World

Apr 25, 2025

Apr 24, 2025

Ovid Therapeutics Inc [OVID] stock for 2,956 USD was sold by ALEXANDER MARGARET A. - knoxdaily.com

Apr 24, 2025

Apr 24, 2025

The OVID Stock Puzzle: Unraveling Ovid Therapeutics Inc’s Fluctuating Performance - investchronicle.com

Apr 24, 2025

Apr 24, 2025

A closer look at Ovid Therapeutics Inc (OVID) is warranted - uspostnews.com

Apr 24, 2025

Apr 20, 2025

Ovid Therapeutics to Present at the 12th International Epilepsy Colloquium | Libero Quotidiano.it - Libero Quotidiano

Apr 20, 2025

Apr 18, 2025

Dravet Syndrome Treatment Market Future Business - openPR.com

Apr 18, 2025

Apr 09, 2025

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Apr 09, 2025

Apr 07, 2025

Ovid Therapeutics stock hits 52-week low at $0.27 By Investing.com - Investing.com South Africa

Apr 07, 2025

Apr 07, 2025

Ovid Therapeutics stock hits 52-week low at $0.27 - Investing.com

Apr 07, 2025

Apr 07, 2025

In Vivo’s 2025 Rising Leaders - insights.citeline.com

Apr 07, 2025

Apr 03, 2025

Ovid Therapeutics Advances Pipeline Amid Financial Progress - TipRanks

Apr 03, 2025

Apr 03, 2025

Ovid Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference - GlobeNewswire

Apr 03, 2025

Apr 02, 2025

Key Brain Medicine Updates: Ovid Therapeutics Takes Center Stage at Major Healthcare Conference - Stock Titan

Apr 02, 2025

Mar 31, 2025

Ovid Therapeutics Inc. (NASDAQ:OVID) Receives $3.03 Consensus Target Price from Brokerages - Defense World

Mar 31, 2025

Mar 28, 2025

Ovid Therapeutics stock hits 52-week low at $0.35 amid downturn By Investing.com - Investing.com South Africa

Mar 28, 2025

Mar 28, 2025

Ovid Therapeutics stock hits 52-week low at $0.35 amid downturn - Investing.com Canada

Mar 28, 2025

Mar 27, 2025

HC Wainwright Lifts Earnings Estimates for Ovid Therapeutics - Defense World

Mar 27, 2025

Mar 26, 2025

FY2026 Earnings Forecast for OVID Issued By HC Wainwright - Defense World

Mar 26, 2025

Mar 25, 2025

Ovid Therapeutics (NASDAQ:OVID) Price Target Lowered to $4.00 at BTIG Research - Defense World

Mar 25, 2025

Mar 24, 2025

Ovid Therapeutics stock target cut to $2 at H.C. Wainwright By Investing.com - Investing.com Australia

Mar 24, 2025

Mar 24, 2025

Ovid Therapeutics stock target cut to $2 at H.C. Wainwright - Investing.com

Mar 24, 2025

Mar 24, 2025

BTIG cuts Ovid Therapeutics stock price target to $4 By Investing.com - Investing.com South Africa

Mar 24, 2025

Mar 24, 2025

BTIG cuts Ovid Therapeutics stock price target to $4 - Investing.com

Mar 24, 2025

Mar 21, 2025

Ovid Therapeutics stock hits 52-week low at $0.42 amid market challenges - Investing.com

Mar 21, 2025

Mar 21, 2025

Ovid Therapeutics stock hits 52-week low at $0.42 amid market challenges By Investing.com - Investing.com South Africa

Mar 21, 2025

Mar 19, 2025

Applied Therapeutics Appoints Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer - GlobeNewswire

Mar 19, 2025

Mar 17, 2025

West syndrome Pipeline 2025: Mechanism of Action, Route - openPR

Mar 17, 2025

Mar 17, 2025

Q1 EPS Forecast for Ovid Therapeutics Raised by Analyst - Defense World

Mar 17, 2025

Mar 15, 2025

What is Wedbush’s Estimate for OVID FY2029 Earnings? - Defense World

Mar 15, 2025